SCHEMBL5223234

SCHEMBL5223234

Nc1nnccc1-c1cccc(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.51
▸ TDO2 P48775 1/20 0.49
▸ MAP4K4 O95819 5/20 0.45
▸ NUDT1 P36639 3/20 0.44
▸ ADORA2A P29274 2/20 0.44
▸ ADORA1 P30542 2/20 0.44
▸ NOTUM Q6P988 2/20 0.44
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ IKBKE Q14164 1/20 0.43
▸ JAK2 O60674 1/20 0.43
▸ TP53 P04637 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5221408 0.79 KDM4E (0.46) MAP4K4ADORA2AADORA1NOTUM
SCHEMBL22588702 0.77 SMARCA2 (0.53) TDO2MAP4K4ADORA2AADORA1NOTUM
SCHEMBL11902083 0.76 MAP4K4 (0.56) DHFRTDO2MAP4K4NUDT1ADORA2A
Hydrochloric Acid SCHEMBL27209691 0.76 SMARCA2 (0.52) TDO2MAP4K4ADORA2AADORA1NPC1
SCHEMBL21223518 0.74 DHFR (0.61) DHFRTDO2MAP4K4ADORA2AADORA1
SCHEMBL5005153 0.72 MAPK14 (0.48) NUDT1ADORA2AADORA1NOTUM
SCHEMBL2417817 0.71 ALDH1A1 (0.46) ADORA2AADORA1NOTUMNPC1RAB9A
SCHEMBL31728471 0.70 MAP4K4 (0.53) DHFRTDO2MAP4K4NUDT1ADORA2A
SCHEMBL21933948 0.69 ALDH1A1 (0.50) DHFRTDO2ADORA2AADORA1NPC1
SCHEMBL913810 0.69 NOTUM (0.47) NOTUMNPC1RAB9ATP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1827434-A2 QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER Amgen Inc. (US) 2007-09-05 — — EP claimed
WO-2006060318-A2 QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER AMGEN INC. (US) 2006-06-08 — — WO claimed
Send feedback